Phillip A. Sharp

Insider Reports History

Entity
Individual
Location
Biogen Inc Legal Department, 14 Cambridge Center, Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Phillip A. Sharp
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phillip A. Sharp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 267K $73.4M $275.00 Jan 23, 2025 by Trust
Vir Biotechnology, Inc. Director Common Stock 121K $185K $1.53 May 22, 2023 Direct
Vir Biotechnology, Inc. Director Common Stock 44.4K $68K $1.53 May 22, 2023 Indirect
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 12.1K $18.4K $1.53 May 22, 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 0 $0 $275.00 Jan 23, 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 17.5K Jun 1, 2022 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 0 Jan 23, 2025 Direct

Insider Reports Filed by Phillip A. Sharp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALNY ALNYLAM PHARMACEUTICALS, INC. Jan 23, 2025 3 -$1.62M 4 Jan 24, 2025 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 16, 2024 1 $0 4 May 20, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 29, 2024 8 -$2.76M 4 Mar 1, 2024 Director
VIR Vir Biotechnology, Inc. May 22, 2023 2 $0 4 May 24, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2023 1 $0 4 May 19, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 15, 2022 10 -$6.62M 4 Aug 17, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
VIR Vir Biotechnology, Inc. May 23, 2022 2 $0 4 May 25, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2022 1 $0 4 May 20, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 9, 2022 3 -$4.16M 4 Feb 11, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Jul 15, 2021 1 $0 4 Jul 19, 2021 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
VIR Vir Biotechnology, Inc. May 21, 2021 2 $0 4 May 25, 2021 Director